These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 22830405)
1. Expression of podoplanin is a rare event in sporadic gastrointestinal stromal tumors and does not influence prognosis. Schoppmann SF; Berghoff AS; Jesch B; Zacherl J; Nirtl N; Jomrich G; Maroske F; Streubel B; Mesteri I; Birner P Future Oncol; 2012 Jul; 8(7):859-66. PubMed ID: 22830405 [TBL] [Abstract][Full Text] [Related]
2. Low frequency of MAP kinase pathway alterations in KIT and PDGFRA wild-type GISTs. Martinho O; Gouveia A; Viana-Pereira M; Silva P; Pimenta A; Reis RM; Lopes JM Histopathology; 2009 Jul; 55(1):53-62. PubMed ID: 19614767 [TBL] [Abstract][Full Text] [Related]
3. High expression of the RNA-binding protein RBPMS2 in gastrointestinal stromal tumors. Hapkova I; Skarda J; Rouleau C; Thys A; Notarnicola C; Janikova M; Bernex F; Rypka M; Vanderwinden JM; Faure S; Vesely J; de Santa Barbara P Exp Mol Pathol; 2013 Apr; 94(2):314-21. PubMed ID: 23295309 [TBL] [Abstract][Full Text] [Related]
4. An overview on molecular biology of KIT/PDGFRA wild type (WT) gastrointestinal stromal tumours (GIST). Nannini M; Biasco G; Astolfi A; Pantaleo MA J Med Genet; 2013 Oct; 50(10):653-61. PubMed ID: 23833252 [TBL] [Abstract][Full Text] [Related]
5. Platelet-derived growth factor receptor family mutations in gastrointestinal stromal tumours. Sihto H; Franssila K; Tanner M; Vasama-Nolvi C; Sarlomo-Rikala M; Nupponen NN; Joensuu H; Isola J Scand J Gastroenterol; 2006 Jul; 41(7):805-11. PubMed ID: 16785193 [TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases. Miettinen M; Sobin LH; Lasota J Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146 [TBL] [Abstract][Full Text] [Related]
7. Multiple gastrointestinal stromal tumors: Clinicopathologic and genetic analysis of 12 patients. Kang DY; Park CK; Choi JS; Jin SY; Kim HJ; Joo M; Kang MS; Moon WS; Yun KJ; Yu ES; Kang H; Kim KM Am J Surg Pathol; 2007 Feb; 31(2):224-32. PubMed ID: 17255767 [TBL] [Abstract][Full Text] [Related]
8. The location of KIT and PDGFRA gene mutations in gastrointestinal stromal tumours is site and phenotype associated. Penzel R; Aulmann S; Moock M; Schwarzbach M; Rieker RJ; Mechtersheimer G J Clin Pathol; 2005 Jun; 58(6):634-9. PubMed ID: 15917417 [TBL] [Abstract][Full Text] [Related]
9. The analysis of status and clinical implication of KIT and PDGFRA mutations in gastrointestinal stromal tumor (GIST). Du CY; Shi YQ; Zhou Y; Fu H; Zhao G J Surg Oncol; 2008 Sep; 98(3):175-8. PubMed ID: 18618605 [TBL] [Abstract][Full Text] [Related]
10. Mutational status of KIT and PDGFRA and expression of PDGFRA are not associated with prognosis after curative resection of primary gastrointestinal stromal tumors (GISTs). Kern A; Görgens H; Dittert DD; Krüger S; Richter KK; Schackert HK; Saeger HD; Baretton G; Pistorius S J Surg Oncol; 2011 Jul; 104(1):59-65. PubMed ID: 21387320 [TBL] [Abstract][Full Text] [Related]
11. Pediatric KIT wild-type and platelet-derived growth factor receptor alpha-wild-type gastrointestinal stromal tumors share KIT activation but not mechanisms of genetic progression with adult gastrointestinal stromal tumors. Janeway KA; Liegl B; Harlow A; Le C; Perez-Atayde A; Kozakewich H; Corless CL; Heinrich MC; Fletcher JA Cancer Res; 2007 Oct; 67(19):9084-8. PubMed ID: 17909012 [TBL] [Abstract][Full Text] [Related]
12. Molecular and clinicopathologic characterization of gastrointestinal stromal tumors (GISTs) of small size. Rossi S; Gasparotto D; Toffolatti L; Pastrello C; Gallina G; Marzotto A; Sartor C; Barbareschi M; Cantaloni C; Messerini L; Bearzi I; Arrigoni G; Mazzoleni G; Fletcher JA; Casali PG; Talamini R; Maestro R; Dei Tos AP Am J Surg Pathol; 2010 Oct; 34(10):1480-91. PubMed ID: 20861712 [TBL] [Abstract][Full Text] [Related]
13. Analysis of mutation and expression of c-kit and PDGFR-alpha gene in gastrointestinal stromal tumor. Zheng S; Chen LR; Wang HJ; Chen SZ Hepatogastroenterology; 2007 Dec; 54(80):2285-90. PubMed ID: 18265649 [TBL] [Abstract][Full Text] [Related]
15. The activated targets of mTOR signaling pathway are characteristic for PDGFRA mutant and wild-type rather than KIT mutant GISTs. Sápi Z; Füle T; Hajdu M; Matolcsy A; Moskovszky L; Márk A; Sebestyén A; Bodoky G Diagn Mol Pathol; 2011 Mar; 20(1):22-33. PubMed ID: 21326036 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic morphological features of PDGFRA-mutated gastrointestinal stromal tumors: molecular genetic and histologic analysis of 60 cases of gastric gastrointestinal stromal tumors. Daum O; Grossmann P; Vanecek T; Sima R; Mukensnabl P; Michal M Ann Diagn Pathol; 2007 Feb; 11(1):27-33. PubMed ID: 17240304 [TBL] [Abstract][Full Text] [Related]
17. Molecular alterations of KIT and PDGFRA in GISTs: evaluation of a Portuguese series. Gomes AL; Gouveia A; Capelinha AF; de la Cruz D; Silva P; Reis RM; Pimenta A; Lopes JM J Clin Pathol; 2008 Feb; 61(2):203-8. PubMed ID: 17827398 [TBL] [Abstract][Full Text] [Related]
19. [Molecular and genetic features of gastrointestinal stromal tumors (GIST)]. Buleje S J; Yábar B A; Guevara-Fujita M; Fujita R Rev Gastroenterol Peru; 2012; 32(4):394-9. PubMed ID: 23307090 [TBL] [Abstract][Full Text] [Related]
20. KIT and PDGFRA mutations and PDGFRA immunostaining in gastrointestinal stromal tumors. Barreca A; Fornari A; Bonello L; Tondat F; Chiusa L; Lista P; Pich A Mol Med Rep; 2011; 4(1):3-8. PubMed ID: 21461555 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]